Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis

Thorax

Volumn 51, Issue 2, 1996, Pages 137-139

  Al Jarad, N ^a   Demertzis, P ^a   Jones, D J Meecham ^a   Barnes, N C ^a   Rudd, R M ^a   Gaya, H ^a   Wedzicha, J A ^a   Hughes, D T ^a   Empey, D W ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Characteristics; Non tuberculous mycobacterial infection; Tuberculosis

Indexed keywords

ETHAMBUTOL; RIFAMPICIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CHILD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; RETROSPECTIVE STUDIES; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 0030049118     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.2.137     Document Type: Review

References (10)

1. Banks J. Environmental mycobacteria. In: Davies PDO, ed. Clinical tuberculosis. London: Chapman and Hall, 1994: 265-75.
2. Wolinsky E. Non-tuberculous mycobacteria and associated disease - state of the art. Am Rev Respir Dis 1979;119: 107-59.
3. Davis PDO. Infection with Mycobacterium kansasii. Thorax 1994;49:435-6.
4. Grange JM, Yates MD. Infections caused by opportunist mycobacteria: a review. J R Soc Med 1986;79:226-9.
5. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax 1984;39:376-82.
6. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales 1970-1979: review of treatment and response. Thorax 1983;38:271.
7. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976;136:67-72.
8. Schraufnagel DE, Leech JA, Polak B. Mycobacterium kansasii: colonisation and disease. Br J Dis Chest 1986;80: 131-7.
9. Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hirst GA. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983;128:1048-50.
10. Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994;49:442-5.